SCHEMBL31324729

SCHEMBL31324729

CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCC(O)C(=O)OCCC

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.51
NFKB1 P19838 1/20 0.51
NFKB2 Q00653 1/20 0.51
RELA Q04206 1/20 0.51
FAAH O00519 2/20 0.50
ALDH1A1 P00352 2/20 0.50
MAPT P10636 2/20 0.50
THRB P10828 1/20 0.50
CNR1 P21554 1/20 0.50
PPARG P37231 2/20 0.49
FFAR1 O14842 1/20 0.49
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.49
USP2 O75604 1/20 0.49
LMNA P02545 1/20 0.49
TP53 P04637 1/20 0.49
CYP3A4 P08684 1/20 0.49
HSPD1 P10809 1/20 0.49
CYP19A1 P11511 1/20 0.49
FABP4 P15090 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31324709 0.89 NFKB1 (0.52) MGLLNFKB1NFKB2RELAFAAH
SCHEMBL5813991 0.88 FFAR1 (0.49) FAAHMAPTPPARGFFAR1MEN1
SCHEMBL1683906 0.88 FFAR1 (0.49) FAAHMAPTPPARGFFAR1MEN1
SCHEMBL5813990 0.88 FFAR1 (0.49) FAAHMAPTPPARGFFAR1MEN1
SCHEMBL31324769 0.86 NFKB1 (0.52) NFKB1NFKB2RELAFAAHCNR1
SCHEMBL354126 0.84 ALDH1A1 (0.50) NFKB1NFKB2RELAFAAHALDH1A1
SCHEMBL19514641 0.83 FAAH (0.49) NFKB1NFKB2RELAFAAHALDH1A1
SCHEMBL1683714 0.81 FAAH (0.49) FAAHMAPTFFAR1USP2LMNA
SCHEMBL8611197 0.81 FAAH (0.52) FAAHFFAR1
SCHEMBL8611202 0.81 FAAH (0.52) FAAHFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025132660-A1 METHOD FOR TREATING HUMAN PERSPIRATION, AND ASSOCIATED COMPOSITION L'OREAL (FR) 2025-06-26 WO disclosed
US-20250009621-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER L'OREAL (FR) 2025-01-09 US disclosed
WO-2025006991-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER L'OREAL (FR) 2025-01-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250009621-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER EBP, ADH1A, ADH1C MGLL 353/4885NFKB1 2596/4885NFKB2 2704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.